Polyomavirus-infected dendritic cells induce antiviral CD8+ T lymphocytes

Journal of Virology

Volumn 74, Issue 9, 2000, Pages 4093-4101

  Drake III, Donald R ^a   Moser, Janice M ^a   Hadley, Annette ^a   Altman, John D ^a   Maliszewski, Charles ^b   Butz, Eric ^b   Lukacher, Aron E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DENDRITIC CELL; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLYOMA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

3T3 CELLS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CRICETINAE; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNODOMINANT EPITOPES; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; POLYOMAVIRUS;

EID: 0033999987     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.9.4093-4101.2000     Document Type: Article

References (64)

1. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102-2106.
2. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.
3. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
4. Bennett, S. R. M., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480.
5. b molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J. Virol. 70:3093-3097.
6. Biczysko, W., D. Solter, M. Pienkowski, and H. Koprowski. 1973. Interaction of early mouse embryos with oncogenic viruses-simian virus 40 and polyoma. Ultrastructural studies. J. Natl. Cancer Inst. 51:1945-1954.
7. Biron, C. A. 1998. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383-390.
8. Borges, L., R. E. Miller, J. Jones, K. Ariail, J. Whitmore, W. Fanslow, and D. H. Lynch. 1999. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo. J. Immunol. 163:1289-1297.
9. Borrow, P., C. F. Evans, and M. B. A. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected cells results in generalized immunosuppression. J. Virol. 69:1059-1070.
10. Campbell, B. A., and L. P. Villarreal. 1986. Lymphoid and other tissue-specific phenotypes of polyomavirus enhancer recombinants: positive and negative combinational effects on enhancer specificity and activity. Mol. Cell. Biol. 6:2068-2079.
11. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261.
12. Clayson, E. T., L. V. Jones Brando, and R. W. Compans. 1989. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J. Virol. 63:2278-2288.
13. Dawe, C. J., R. Freund, G. Mandel, K. Ballmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice: characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:243-261.
14. de Bergeyck, V., E. De Plaen, P. Chomez, T. Boon, and A. Van Pel. 1994. An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur. J. Immunol. 24:2203-2212.
15. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
16. 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252:275-284.
17. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castognoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cell directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-411.
18. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156-1159.
19. Gagliardi, M. C., G. De Petrillo, S. Salemi, L. Boffa, M. G. Longobardi, P. Dellabona, G. Casorati, N. Tanigaki, R. Harris, and A. Lanzavecchia. 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7: 1741-1752.
20. Gong, J. L., K. M. McCarthy, R. A. Rogers, and E. E. Schneeberger. 1994. Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulates. Immunology 81:343-351.
21. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumors. Adv. Immunol. 49: 281-355.
22. + BW5147 transfectant and the 2C CTL line. Immunogenetics 36:283-293.
23. + T-cell memory determined by clonal burst size. Nature 369:652-654.
24. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321-331.
25. Knight, S. C., and A. J. Stagg. 1993. Antigen-presenting cell types. Curr. Opin. Immunol. 5:374-382.
26. Kos, F. J., and E. G. Engelman. 1996. Immune regulation: a critical link between NK cells and CTLs. Immunol. Today 17:174-176.
27. Kruisbeek, A. M. 1994. Production of mouse T cell hybridomas, p. 3.14.1-3.14.11. In J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
28. Kurts, C., J. F. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath. 1998. Major histocompatibility complex class l-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188:409-414.
29. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648-652.
30. Liu, Y., and P. S. Linsley. 1992. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:265-270.
31. Ljunggren, G., H.-G. Ljunggren, and T. Dalianis. 1994. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198: 714-716.
32. Lu, L., M. Hsieh, T. B. Oriss, P. A. Morel, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 84:127-134.
33. Ludewig, B., S. Oehen, F. Barchiesi, R. A. Schwendener, H. Hengartner, and R. M. Zinkernagel. 1999. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163: 1839-1844.
34. S: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 196:241-248.
35. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683-1692.
36. + T cells in vivo during infection and tumor rejection. J. Immunol. 163:3369-3378.
37. k-restricted epitope in the middle T protein. J. Immunol. 160:1724-1734.
38. Lyman, S. D. 1996. Biology of Flt3 ligand and receptor. Int. J. Hematol. 62: 63-73.
39. Lynch, D. H., A. Andreasen, E. Maraskovsky, J. Whitmore, R. E. Miller, and J. C. Schuh. 1997. Flt3-ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med. 3:625-631.
40. + and CD8α dendritic cells in the induction of primary immune responses in vivo. J. Leukoc. Biol. 66:242-246.
41. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1053-1962.
42. Mattern, C. F. T., K. K. Takemoto, and W. A. Daniel. 1966. Replication of polyoma virus in mouse embryo cells: electron microscopic observations. Virology 30:242-256.
43. Pallas, D. C., C. Schley, M. Mahoney, E. Harlow, B. S. Schaffhausen, and T. M. Roberts. 1986. Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J. Virol. 60:1075-1084.
44. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-358.
45. Peron, J.-M., C. Esche, V. M. Subbotin, C. Maliszewski, M. T. Lotze, and M. R. Shurin. 1998. Flt3-ligand administration inhibits liver metastases: role of NK cells. J. Immunol. 161:6164-6170.
46. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findley, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362.
47. Piatti, P. G., K. A. Gottlieb, J. A. Taylor, and L. P. Villarreal. 1998. Approaches to study interactions between small DNA viruses and differentiated tissue. Methods 16:62-82.
48. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo. J. Immunol. 159:2222-2231.
49. Pulendran, B., J. L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C. R. Maliszewski. 1998. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J. Exp. Med. 188:2075-2082.
50. + T-helper and a T-killer cell. Nature 393:474-478.
51. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726.
52. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
53. Schoenberger, S. P., R. E. M. Toes, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483.
54. Selin, L. K., and R. M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J. Immunol. 158:5366-5373.
55. Shaw, S. G., A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vanjanovic. 1998. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161:2817-2824.
56. Shurin, M. R., P. P. Pandharipande, T. D. Zorina, C. Haluszezak, V. Subbotin, O. Hunter, A. Brumfield, W. J. Storkus, E. Maraskovsky, and M. T. Lotze. 1997. FLT3-ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol. 179:174-184.
57. Sigal, L. J., S. Crotty, R. Andino, and K. L. Rock. 1999. Cytotoxic T-cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen. Nature 398:26-27.
58. Tay, C. H., E. Szomolanyi-Tsuda, and R. M. Welsh. 1998. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230:193-220.
59. Toujas, L., J. G. Delcros, E. Diez, N. Gervois, G. Semana, G. Corradin, and F. Jotereau. 1997. Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunology 91:635-642.
60. van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Marali-Krishna, L. L. Lau, S. Southjwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543-5554.
61. Ward, P. L., H. Koeppen, T. Hurteau, and H. Schreiber. 1989. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170:217-225.
62. Weaver, C. T., and E. R. Unanue. 1990. The costimulatory function of antigen-presenting cells. Immunol. Today 11:49-55.
63. Yi, X., J. Peterson, and R. Freund. 1997. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in She binding. J. Virol. 71:6279-6286.
64. + T lymphocyte responses in vitro using dendritic cells. J. Immunol. 162:5197-5204.